Loading clinical trials...

A Phase II Study of the Effect of a Low Calorie Diet on Patients Undergoing Liver Resection | Clinical Trials | Clareo Health

COMPLETEDNA

A Phase II Study of the Effect of a Low Calorie Diet on Patients Undergoing Liver Resection

A Randomized Phase II Study of the Effect of a Low Calorie Diet on Patients Undergoing Liver Resection

NCT01645852•Dartmouth-Hitchcock Medical Center

View on ClinicalTrials.gov

Summary

The purpose of this study is to measure the effect of a short-term low calorie diet on patients with a Body Mass Index (BMI) over 25 who are undergoing liver surgery.

Eligibility

Age

18 - No limit years

Sex

ALL

Healthy Volunteers

Inclusion Criteria

•Age 18 or greater
•Clinical indication for a therapeutic liver resection
•BMI of 25 kg/m2 or greater
•Informed Consent

Exclusion Criteria

•Inability to comply with the pre-op diet
•Patients who have lost 5% or more of their usual body weight over the preceding one month
•Female patients of childbearing age who have a positive pregnancy test

Locations (3)

UMass Memorial Medical Center

Worcester, Massachusetts, United States

Dartmouth-Hitchcock Medical Center

Lebanon, New Hampshire, United States

Fletcher Allen Health Care

Burlington, Vermont, United States

Key Dates

Start Date

June 1, 2012

Primary Completion Date

December 1, 2016

Completion Date

December 1, 2016

Last Updated

February 8, 2017

Enrollment

ACTUAL participants

Conditions

Nonalcoholic Fatty Liver DiseaseHepatic SteatosisSteatohepatitis

Interventions

Optifast 800

DIETARY_SUPPLEMENT

LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis

NCT06632444

Metabolic Dysfunction Associated Steatohepatitis (MASH)Liver Fibrosis

View study

RECRUITING

A Longitudinal Observational Study of Patients With Nonalcoholic Steatohepatitis (NASH) and Related Conditions Across the Entire Spectrum of Nonalcoholic Fatty Liver Disease (NAFLD)

NCT02815891

Nonalcoholic Fatty LiverNonalcoholic Steatohepatitis

View study

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: February 8, 2017Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions

A Phase II Study of the Effect of a Low Calorie Diet on Patients Undergoing Liver Resection

Inclusion Criteria

Exclusion Criteria

LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis

A Longitudinal Observational Study of Patients With Nonalcoholic Steatohepatitis (NASH) and Related Conditions Across the Entire Spectrum of Nonalcoholic Fatty Liver Disease (NAFLD)

iWAIST Trial: ERCG (Endoscopic Radial Compression Gastroplasty) vs Optimized Lifestyle Intervention for Weight Loss

Identification of Liver Fibrosis Biomarkers

Study of the Link Between MASH ( Metabolic Dysfunction-Associated Steatohepatitis) and MAMs (Mitochondria-Associated Membranes ) Alteration in Patients Undergoing Bariatric Surgery - MAMBA

Using Hydroxychloroquine (HCQ) to Treat Steatohepatitis